TSPO配体-1是AUTAC4(HY-134640)的配体,可用于合成ProTAC。TSPO配体-1是一种线粒体外膜跨膜结构域蛋白,能结合AUTAC4并调节线粒体自噬,从而促进靶向线粒体更新。此外,它还参与胆固醇从线粒体外膜到内膜的转运,并作为脑损伤和神经变性的敏感生物标志物[1][2]。
中文名称 | 英文名称 | CAS号 | 化学式 | 分子量 |
---|---|---|---|---|
—— | 2-Phenylindol-3-ylglyoxylamide | 408310-88-3 | C16H12N2O2 | 264.283 |
—— | methyl 2-oxo-2-(2-phenyl-1H-indol-3-yl)acetate | 931587-80-3 | C17H13NO3 | 279.295 |
—— | 2-oxo-2-(2-phenyl-1H-indol-3-yl)-N-propylacetamide | —— | C19H18N2O2 | 306.364 |
—— | N-ethyl-N-methyl-2-oxo-2-(2-phenyl-1H-indol-3-yl)acetamide | 1060748-90-4 | C19H18N2O2 | 306.364 |
—— | 2-Phenyl-3-diethylaminoglyoxaloyl-indol | 4560-19-4 | C20H20N2O2 | 320.391 |
—— | N-butyl-N-methyl-2-oxo-2-(2-phenyl-1H-indol-3-yl)acetamide | 1060748-92-6 | C21H22N2O2 | 334.418 |
—— | 1-(4-methylpiperazin-1-yl)-2-(2-phenyl-1H-indol-3-yl)ethane-1,2-dione | —— | C21H21N3O2 | 347.417 |
—— | N-methyl-2-oxo-N-pentyl-2-(2-phenyl-1H-indol-3-yl)acetamide | 1060748-93-7 | C22H24N2O2 | 348.445 |
—— | N-butyl-N-ethyl-2-oxo-2-(2-phenyl-1H-indol-3-yl)acetamide | 1197829-40-5 | C22H24N2O2 | 348.445 |
—— | 1-(2-phenyl-1H-indol-3-yl)-2-(pyrrolidin-1-yl)ethane-1,2-dione | —— | C20H18N2O2 | 318.375 |
—— | (2-phenyl-indol-3-yl)-glyoxylic acid piperidide | 102318-27-4 | C21H20N2O2 | 332.402 |
—— | (2-phenyl-indol-3-yl)-glyoxylic acid-(benzyl-methyl-amide) | 102754-29-0 | C24H20N2O2 | 368.435 |
—— | N,N-dibenzyl-2-oxo-2-(2-phenyl-1H-indol-3-yl)acetamide | 4560-09-2 | C30H24N2O2 | 444.533 |
1-(2-甲基哌啶-1-基)-2-(2-苯基-1H-吲哚-3-基)乙烷-1,2-二酮 | 2-Methyl-1-(oxo(2-phenyl-1H-indol-3-yl)acetyl)piperidine | 71765-55-4 | C22H22N2O2 | 346.429 |
—— | N-benzyl-N-ethyl-2-oxo-2-(2-phenyl-1H-indol-3-yl)acetamide | 1060748-70-0 | C25H22N2O2 | 382.462 |
1-(氧代(2-苯基-1H-吲哚-3-基)乙酰基)-4-苯基-4-哌啶醇 | 1-(Oxo(2-phenyl-1H-indol-3-yl)acetyl)-4-phenyl-4-piperidinol | 71765-54-3 | C27H24N2O3 | 424.499 |
2-(2-苯基-1H-吲哚-3-基)-乙胺 | 2-(2-phenyl-1H-indol-3-yl)ethylamine | 1217-80-7 | C16H16N2 | 236.316 |
—— | (1-methyl-2-phenyl-indol-3-yl)-glyoxylic acid dipropylamide | 112550-92-2 | C23H26N2O2 | 362.472 |
—— | N-butyl-N-methyl-2-(1-methyl-2-phenyl-1H-indol-3-yl)-2-oxoacetamide | 1259406-14-8 | C22H24N2O2 | 348.445 |
—— | N-butyl-N-ethyl-2-(1-methyl-2-phenyl-1H-indol-3-yl)-2-oxoacetamide | 1259406-13-7 | C23H26N2O2 | 362.472 |
—— | N-methyl-2-(1-methyl-2-phenyl-1H-indol-3-yl)-2-oxo-N-pentylacetamide | 1259406-15-9 | C23H26N2O2 | 362.472 |
—— | N,N-dibutyl-2-(1-methyl-2-phenyl-1H-indol-3-yl)-2-oxoacetamide | 1259406-11-5 | C25H30N2O2 | 390.525 |
—— | 2-(2-phenyl-1H-indol-3-yl)ethan-1-ol | 92962-52-2 | C16H15NO | 237.301 |
—— | N,N-dihexyl-2-(1-methyl-2-phenyl-1H-indol-3-yl)-2-oxoacetamide | 1259406-12-6 | C29H38N2O2 | 446.633 |
—— | N-benzyl-N-methyl-2-(1-methyl-2-phenyl-1H-indol-3-yl)-2-oxoacetamide | 1259406-16-0 | C25H22N2O2 | 382.462 |
—— | (2-phenylindol-3-yl)glyoxylyl-L-leucine-L-valine methyl ester | —— | C28H33N3O5 | 491.587 |
—— | (1-methyl-2-phenyl-indol-3-yl)-glyoxylic acid-(ethyl-benzyl-amide) | 102947-86-4 | C26H24N2O2 | 396.489 |
3-(2-(2-甲基-1-哌啶基)乙基)-2-苯基-1H-吲哚 | 3-[2-(2-methylpiperidin-1-yl)ethyl]-2-phenyl-1H-indole | 71765-63-4 | C22H26N2 | 318.462 |
—— | 4-Piperidinol, 4-phenyl-1-(2-(2-phenyl-1H-indol-3-yl)ethyl)- | 71765-62-3 | C27H28N2O | 396.532 |
—— | 2-(1-benzyl-2-phenyl-1H-indol-3-yl)ethanol | 401934-76-7 | C23H21NO | 327.426 |